Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit

World News: . []

BASEL Switzerland Dec 06 2018 GLOBE NEWSWIRE -- Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences today announced that the company will present new data on cerdulatinib during the 3 Annual Inflammatory Skin Disease Su mmit (I...

More news and information about Dermavant Sciences, Inc.

Published By:

Globe Newswire: 12:00 GMT Thursday 6th December 2018

Published: .

Search for other references to "dermavant" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us